3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Toxemia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Myocarditis
1
Muscle Weakness
1
Melanoma
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma in Situ
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
28
Paclitaxel
24
Carboplatin
19
Bevacizumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
Doxorubicin
8
Cisplatin
8
Biopsy
8
olaparib
7
lenvatinib
7
Taxes
7
Letrozole
7
Megestrol Acetate
6
Fulvestrant
6
durvalumab
5
dostarlimab
5
Nivolumab
5
Medroxyprogesterone Acetate
5
Gemcitabine
5
trastuzumab deruxtecan
4
abemaciclib
4
X-Rays
4
Trastuzumab
4
Tirzepatide
4
Progestins
4
Oxaliplatin
4
Immunoglobulin G
4
Fluorouracil
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Positron-Emission Tomography
×
90 days
×
Clear all
No trials found.